Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose: : IL-1ß signalling has critical role on pathogenesis of various inflammatory arthritis including rheumatoid arthritis (RA). We aimed to investigate the therapeutic effects of human IL-1 receptor antagonist with Fc fragment (hIL-1Ra-Fc) on autoimmune arthritis and find out the possible mechanisms by which hIL-1RA-Fc has anti-arthritic effects in a murine model of RA and arthritis patient.
Methods: Collagen-induced arthritis (CIA) murine model was induced in DBA/1J mice. The levels of various cytokines were determined by using enzyme-linked immunosorbent assay. The joints of mouse were assessed for clinical arthritis score and histologic features. Th17 cells and Treg cells were stained by using antibodies specific for CD4, IL-17, CD25, and FoxP3. Osteoclastogenesis was determined by TRAP stain and real-time PCR.
Results: hIL-1RA-Fc reduced the clinical arthritis, histological inflammation and cartilage score in CIA model. The expression of proinflammatory cytokines, VEGF, and RANK were reduced in affected joint of hIL-1Ra-Fc treated mice. hIL-1Ra-Fc treated mice showed decreased number of Th17 cells with increased Treg cells in spleens. hIL-1Ra-Fc reduced Th17 cell differentiation by inactivation of STAT-3 signalling, reciprocally induced Treg cell differentiation through STAT-5 signalling. In addition, Suppression of gene expression of IL-17, TNF-α, RANKL and VEGF were decreased, while increased Foxp3 gene expression in PBMC of RA patients after administration of hIL-1Ra-Fc.
Conclusion: The anti-arthritis effects of hIL-1RA-Fc are associated with regulating balance between Th17 cells and Treg cells and with suppressing osteoclastogenesis and angiogenesis in affected joints.
Disclosure:
H. K. Min,
None;
S. H. Park,
None;
M. L. Cho,
None;
J. H. Ju,
None;
S. K. Kwok,
None;
S. Y. Lee,
None;
S. M. Jung,
None;
K. S. Park,
None;
J. Lee,
None.
« Back to 2014 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-1-receptor-antagonis-il-1ra-fc-ameliorate-autoimmune-arthritis-by-regulation-of-the-th17-cellstreg-balance-and-arthrogenic-cytokine-activation/